These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 22381083)
1. The role of procalcitonin in adult patients with community-acquired pneumonia--a systematic review. Berg P; Lindhardt BØ Dan Med J; 2012 Mar; 59(3):A4357. PubMed ID: 22381083 [TBL] [Abstract][Full Text] [Related]
2. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia. Lindstrom ST; Wong EK Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis. Liu D; Su LX; Guan W; Xiao K; Xie LX Respirology; 2016 Feb; 21(2):280-8. PubMed ID: 26662169 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Don M; Valent F; Korppi M; Falleti E; De Candia A; Fasoli L; Tenore A; Canciani M Scand J Infect Dis; 2007; 39(2):129-37. PubMed ID: 17366029 [TBL] [Abstract][Full Text] [Related]
5. The value of procalcitonin level in community-acquired pneumonia in the ED. Park JH; Wee JH; Choi SP; Oh SH Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049 [TBL] [Abstract][Full Text] [Related]
8. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199 [TBL] [Abstract][Full Text] [Related]
9. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia. Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498 [TBL] [Abstract][Full Text] [Related]
11. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia. Ugajin M; Yamaki K; Hirasawa N; Yagi T Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878 [TBL] [Abstract][Full Text] [Related]
13. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia? Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers and community-acquired pneumonia: tailoring management with biological data. Torres A; Ramirez P; Montull B; Menéndez R Semin Respir Crit Care Med; 2012 Jun; 33(3):266-71. PubMed ID: 22718212 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia. Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of procalcitonin in community-acquired pneumonia. Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B; Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156 [TBL] [Abstract][Full Text] [Related]
17. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia. Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948 [TBL] [Abstract][Full Text] [Related]
18. Procalcitonin kinetics in Legionella pneumophila pneumonia. de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643 [TBL] [Abstract][Full Text] [Related]
19. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM Crit Care; 2011; 15(2):R88. PubMed ID: 21385367 [TBL] [Abstract][Full Text] [Related]
20. The role of procalcitonin in community-acquired pneumonia: a literature review. Lee M; Snyder A Adv Emerg Nurs J; 2012; 34(3):259-71. PubMed ID: 22842969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]